Infographic: Differentiating iPSCs – Which Approach Works Best?

Current methods to generate cells from human-induced pluripotent stem cells (iPSCs) lack reproducibility and scalability. This raises challenges for disease research, drug discovery and cell therapy development due to unreliable data and long experimental timelines. However, there is a new technology on the block, enabling reproducible, consistent and scalable production of physiologically relevant human cell models giving scientists more confidence in their experiments!

Download this infographic by bit.bio to compare traditional methods to the new precision reprogramming technology and discover its benefits including:

  • Higher culture purity with defined cell identity
  • Unlimited and consistent manufacture of any human cell
  • Short culture time

View the infographic here

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free